EZZ continues to capitalise on growing skin care and health supplement markets across Asia Pacific
By Louis Allen – July 27, 2022 EZZ Life Science’s (ASX: EZZ) fourth quarter results (Q4 FY2022) have been highlighted by a rise in sales, with receipts from customers increasing 16% to $4.6 million compared to the previous quarter. The…